SOURCE: Neuro Resource Group

December 10, 2007 07:00 ET

Neuro Resource Group: New Publication of a Peer-Reviewed Clinical Trial

Improvements in Recovery Rates After Interactive Stimulation Suggests Reduction in the Length of In-Patient Stay

PLANO, TX--(Marketwire - December 10, 2007) - Neuro Resource Group (NRG), the manufacturer of InterX® products, announced the publication of a peer-reviewed clinical trial in the Journal of Bone & Joint Surgery (Br), Vol 89-B11, Issue 11.

The study examines the effect of interactive neurostimulation in the post-operative recovery of patients with fracture of the femur. A random controlled trial (RCT) in a group of 60 patients provides outcome measurements of VAS pain, Brief Pain Inventory and an overall assessment of outcome by the surgeon. There were significantly better results for the patients receiving treatment with InterX® in addition to standard rehab care (repeated measures analysis of variance, P < .001).

Since its formation in 2004, Neuro Resource Group (NRG) has been committed to investing its resources into the research of the effects and associated outcomes observed with InterX® Therapy as an adjunct to standard rehabilitation. A total of 8 random controlled trials (RCT) have already been completed and several more are in progress. A study that examines the 'influence of neurostimulation in a transected medial collateral ligament in sheep' was recently presented at the 6th Combined Meeting of the Orthopaedic Research Society and is due to be published in 2008.

"We are excited about the findings of this study," said Sean Browne, President and CEO of NRG. "This is one more significant clinical study that reinforces what thousands of patients tell us daily. This study further supports our mission of helping people redefine their expectations for an active life," said Browne.


InterX® products are portable, handheld neurostimulation devices that provide a safe, non-drug, non-invasive therapy that enhances rehabilitation following injury or surgery. InterX® products also provide an effective treatment for chronic pain and conditions, helping people who are suffering from pain and poor function to get back to an active life.

InterX® products are available to licensed healthcare professionals, including MDs, physical therapists and chiropractors for the treatment of a wide range of acute and chronic pain conditions; InterX® is also widely used throughout sports medicine. InterX personal products are available to individuals. (Prescriptions are required in US & Canada.)

InterX® delivers highly specific, targeted, dynamic electrical stimulation resulting in effective pain relief. This unique technology has been developed and re-designed to provide InterX® FDA cleared medical products with defined treatment applications for healthcare professionals.

InterX® Clients

The list of clients whose patients and/or teams have been changed by InterX® products is truly impressive and includes:

--  Medical Professionals across the US and International
--  The US Military
--  Hospitals and Clinics in the US and International
--  Professional Sports teams in the NFL, NBA, MLB, NHL and MLS
--  Professional Rugby and International Football


Neuro Resource Group (NRG) specializes in the development, design and manufacture of innovative medical products for the treatment of acute and chronic injury, rehabilitation, and pain management. The Company's management team has extensive experience in the healthcare industry and is committed to providing products and developing training materials and protocols that help to improve the quality of patient's lives and enhance athletic performance. Neuro Resource Group 1100 Jupiter Rd., Suite 190, Plano, TX 75074. 972-665-1810

Contact Information